update
ICH completes draft Q11 implementation Q&A; welcomes ANVISA and MFDS
The ICH has put together a draft Q&A document to clarify Q11 guidelines on drug active ingredient production.
Archives for November 29, 2016
update
Patheon buys Roche's Xeloda API plant and signs supply deal
Patheon has bought a US API facility from Roche in a deal that will also see the CMO supply the Swiss firm with drug ingredients.
How CMOs can fight back against the counterfeit drug market
Fighting counterfeit medications is a “team sport,” and contract manufacturing organizations (CMOs) play a “pivotal role,” says Applied DNA Sciences.
Cellectar secures 'extended partnership' to support clinical trial needs
Cellectar Biosciences has announced a partnership with the Centre for Probe Development and Commercialization (CPDC) to establish manufacturing capacity ahead of the company’s NCI-supported Ph II trial of CLR 131.
WuXi AppTec inks new manufacturing services agreement with Lion Biotechnologies
Lion Biotechnologies has expanded its ‘favorable’ existing relationship with WuXi AppTec to manufacture its autologous cell therapy products.